Paradigm Biopharmaceuticals | PAR - Ebitda

Prezzo Delle Azioni
0.19
Cambio Giornaliero
-0.04 -15.56%
Mensile
-26.92%
Annuale
-38.71%
Q2 Previsione
0.22




Ebitda Cambiamento Data
Avita Medical AUD -9.69M 12.21M 2025-12
Medical Developments International AUD 1.78M 3.78M 2024-12
Neuren Pharmaceuticals AUD 11.14M 165.56M 2025-12
Pacific Edge NZD -13.97M 332K 2024-09
PYC Therapeutics AUD -22.79M 1.5M 2025-12
Telix Pharmaceuticals AUD 18.42M 14.82M 2025-12